Home / About PPME / News
News
Calcium supplements and the risk of cardiovascular events
2010-09-07 Osteoporosis is a major cause of morbidity and mortality in older people and most guidelines recommend adequate calcium intake as an integral part of the prevention...
Read more
Lilly fighting generic competition
2010-09-07 Eli Lilly and Co. is seeking a temporary block on sales of generic versions of its drug atomoxetine (Strattera) while it appeals against a ruling that declared a ke...
Read more
Big fuss about ARB study
2010-09-03 The EMA plans to review the possible risk of cancer in patients taking angiotensin-receptor blockers (ARBs), based on a meta-analysis in Lancet Oncology that sugges...
Read more
Adjuvant chemotherapy following radical cystectomy
2010-09-03 The use of adjuvant chemotherapy (AC) after radical cystectomy is of benefit to patients with high-risk bladder cancer.
A lack of evidence for use of AC in patien...
Read more
DMARDs should remain first-choice drugs in RA
2010-08-17 A systematic review and meta-analysis of published research indicates that in patients with rheumatoid arthritis (RA), combinations of disease-modifying anti-rheuma...
Read more
Infection prophylaxis for PEG
2010-08-13 The deposition of co-trimoxazole solution into a newly inserted percutaneous endoscopic gastrostomy (PEG) tube is at least as effective at preventing wound infectio...
Read more
Nanoparticle research
2010-08-13 Clusters of heated, magnetic nanoparticles targeted at cell membranes can remotely control ion channels, neurons and even animal behaviour, according to a paper pu...
Read more
Low vitamin D levels in diabetics
2010-08-11 A small but long-term observational study suggests that low vitamin D levels may be associated with increased risk of all-cause and cardiovascular mortality in pati...
Read more
Diabetes UK launches new online diabetes risk test
2010-08-11 On 6 July 2010, Diabetes UK launched a new online type 2 diabetes risk score test that is more accurate, personal and user-friendly. The test, which consists of sev...
Read more
Imatinib faces competition
2010-08-06 Two head-to-head trials involving chronic myeloid leukaemia (CML) found patients responding better to dasatinib than imatinib after a year [1] and likewise better t...
Read more
Polypill trial starts
2010-08-06 In 2003 a combination tablet was proposed to prevent heart disease, recommended for use by anyone over the age of 55, or with existing high blood pressure, heart di...
Read more
Roflumilast, new COPD drug
2010-08-04 The European Commission has approved Nycomed's Daxas (roflumilast) as a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD), the co...
Read more
Last update: 2008-09-06 |
Go Back |
Print View
